The Role of Plasma Protein Binding in Drug Discovery

Pharmacokinetic Profiling in Drug Research

Volumn , Issue , 2007, Pages 119-141

  Fessey, Roger E ^a   Austin, Rupert P ^a   Barton, Patrick ^a   Davis, Andrew M ^a   Wenlock, Mark C ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Biological strategies; Drug discovery; Role of plasma protein binding

Indexed keywords

PROTEINS;

BIOLOGICAL STRATEGIES; DRUG DISCOVERY; PLASMA PROTEIN BINDING;

BIOCHEMISTRY;

EID: 84956677450     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783906390468.ch8     Document Type: Chapter

References (53)

1. G. R. Wilkinson, Drug Metab. Rev. 1983, 14, 427.
2. M. Laznicek, A. Laznickova, J. Pharm. Biomed. Anal. 1995, 13, 823.
3. J. P. Tillement, G. Houin, R. Zini, S. Urien, E. Albengres, J. Barre, M. Lecomte, P. D Athis, B. Sebille, in 'Advances in Drug Research, Vol. 13 , Ed. B. Testa, Academic Press, London, 1984, p. 59-93.
4. M. Rowland, T. N. Tozer, 'Clinical Pharmacokinetics-Concepts and Applications , 3rd edn., LippincottWilliams & Wilkins, London, 1995.
5. B. B. Brodie, H. Kurtz, L. J. Schanker, J. Pharmacol. Exp. Ther. 1960, 130, 20.
6. F. Herve, S. Urien, E. Albengres, J. Duche, J. P. Tillement, Clin. Pharmacokinet. 1994, 26, 44.
7. K.Valko, S. Nunhuck, C. Bevan, M. H. Abraham,D. Reynolds, J. Pharm. Sci. 2003, 92, 2236.
8. H. van deWaterbeemd,D. A. Smith, B. C. Jones, J. Comput.-Aided Mol. Des. 2001, 15, 273.
9. A. M. Davis, R. Riley, D. R. Flower, in 'Drug Design: Cutting Edge Approaches , Ed. D. R. Flower, Royal Society of Chemistry, Cambridge, UK, 2002, p. 106-123.
10. S. Toon, M. Rowland, J. Pharmacol. Exp. Ther. 1983, 225, 752.
11. M. Laznicek, J. Kvetina, J. Mazak, V. Krch, J. Pharm. Pharmacol. 1987, 39, 79.
12. M. Lobell, V. Sivarajah, Mol. Divers. 2003, 7, 69.
13. J. Koch-Weser, E.M. Sellers, Med. Intelligence 1976, 294, 311.
14. I. M. Klotz, Acc. Chem. Res. 1974, 7, 162.
15. I. M. Klotz, D. L. Hunston, J. Biol. Chem. 1975, 250, 3001.
16. I. M. Klotz, D. L. Hunston, Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 4959.
17. H. G.Weder, J. Schildknecnt, P. Kesselring, Am. Lab. 1971, 15.
18. I. Kariv, H. Cao, K. R. Oldenburg, J. Pharm. Sci. 2001, 90, 580.
19. I. M. Klotz, F. M. Walker, R. B. Pivan, J. Am. Chem. Soc. 1946, 68, 1486.
20. J. H. Lin, D. M. Cocchetto, D. E. Duggan, Clin. Pharmacokinet. 1987, 12, 402.
21. P. B. Rheberg, Acta Phys. Scand. 1943, 5, 305.
22. Z. Liu, F. Li, Y. Huang, Biomed. Chromatogr. 1999, 13, 262.
23. S. P. Colowick, F. C.Womack, J. Biol. Chem. 1968, 244, 774.
24. S. Hall, M. Rowland, J. Pharmacol. Exp. Ther. 1983, 227, 174.
25. L. Aarons, D. M. Grennan, M. Siddiqui, Eur. J. Clin. Pharmacol. 1983, 25, 815.
26. J.Yuan,D. C.Yang, J. Birkmeier, J. Stolzenbac, J. Pharmacokinet. Biopharm. 1995, 23, 41.
27. D. S. Hage, J. Austin, J. Chromatogr., B 2000, 739, 39.
28. C. F. Chignell, 'Actualit's de Chimie Th'rapeutique, Vol. 8 , Soci't' de Chimie Th'rapeutique, Paris, 1981, p. 291-302.
29. C. Bertucci, P. Salvadori, E. Domenici, in 'The Impact of Stereochemistry on Drug Development and Use , Eds.H. Y. Aboul-Enein, I.W.Wainer,Wiley, NewYork, 1997, p. 521 -543.
30. C. T. Hartrick, W. E. Dirkes, D. E. Coyle, P. Prithvi Raj, D. D. Denson, Clin. Pharmacol. Ther. 1984, 36, 546.
31. E. N. Fung, Y. Chen, Y. Y. Lau, J. Chromatogr., B 2003, 795, 187.
32. T. F. Blaschke, Clin. Pharmacokinet. 1977, 2, 32.
33. K. M. Piafsky, Clin. Pharmacokinet. 1980, 5, 246.
34. U. Kragh-Hansen, S. Brennan, M. Galliano, O. Sugita, Mol. Pharmacol. 1990, 37, 232.
35. B. Fichtl, A. v. Nieciecki, K. Walter, in 'Advances in Drug Research, Vol. 20 , Ed. B. Testa, Academic Press, London, 1991, p. 117 -166.
36. F. Lombardo, R. S. Obach, M. Y. Shalaeva, F. Gao, J. Med. Chem. 2002, 45, 2867.
37. S. Zhou, J. W. Paxton, P. Kestell, M. D. Tingle, J. Pharm. Pharmacol. 2001, 53, 463.
38. W. Loscher, J. Pharmacol. Exp. Ther. 1978, 204, 255.
39. K. C. Beaumont, P. V. Macrae, C. M. Miller, D. A. Smith, P. Wright, Br. J. Clin. Pharmacol. 1994, 38, 179.
40. D. A. Smith, B. C. Jones, D. K. Walker, Med. Res. Rev. 1996, 16, 243.
41. L. Z. Benet, B. Hoener, Clin. Pharmacol. Ther. 2002, 71, 115.
42. G. Levy, A. Yacobi, J. Pharm. Sci. 1974, 63, 805.
43. A. Yacobi, G. Levy, J. Pharm. Sci. 1975, 64, 1995.
44. G. H. Evans, A. S. Nies, D. G. Shand, J. Pharmacol. Exp. Ther. 1973, 186, 114.
45. K. Stoeckel, P. J. McNamara, R. Brandt, H. Plozza-Nottebrock, W. H. Ziegler, Clin. Pharmacol. Ther. 1981, 29, 650.
46. S. Oie, T. N. Tozer, J. Pharm. Sci. 1979, 68, 1203.
47. F. Lombardo, R. S. Obach, M. Y. Shalaeva, F. Gao, J. Med. Chem. 2004, 47, 1242.
48. R. S. Obach, J. G. Baxter, T. E. Liston, B. M. Silber, B. C. Jones, F. Macintyre, D. J. Rance, P.Wastall, J. Pharmacol. Exp. Ther. 1997, 283, 46.
49. H. Kurz, B. Fichtl, Drug Metab. Rev. 1983, 14, 467.
50. P. E. Rolan, Br. J. Clin. Pharmacol. 1994, 37, 125.
51. J. Hirate, C. Zhu, I. Horikoshi, S. Nagase, Int. J. Pharm. 1990, 65, 149.
52. F. A. van den Ouweland, M. J. A. M. Franssen, L. B. A. van de Putte, Y. Tan, C. A. M. van Ginneken, F.W. J. Gribnau, Br. J. Clin. Pharmacol. 1987, 23, 189.
53. F. A. van den Ouweland, F.W. J. Gribnau,C. A. M. van Ginneken,Y. Tan, L. B. A. van de Putte, Clin. Pharmacol. Ther. 1988, 43, 79.